Less Ads, More Data, More Tools Register for FREE

IP Group looking ahead with confidence

Thu, 22nd Aug 2013 09:23
IP Group, which develops intellectual property-based businesses, posted a half year statutory loss but said it was looking ahead with confidence. The statutory loss for the period totalled £2.0m, compared to £28.7m profit the same period the previous year, resulting from a reduced change in fair value of equity and debt investments, which fell from £32.3m to £2.2m year-on-year. Net assets rose to £261.6m from £250.7m a year earlier. The fair value of the investment portfolio rose from £171.5m to £191.9m, while the value of the ten largest holding climbed from £132.2m to £145.7m. Portfolio realisations rose from £0.5m to £2.8m. Alan Aubrey, Chief Executive of IP Group, said: "It has been another productive first half for both the group and its portfolio companies. "In the portfolio, not only have some notable commercial and technical milestones been achieved, but it was also pleasing that our companies raised approximately £55m of financing during the period." Looking ahead, the company said it was feeling confident in its "ongoing ability to deliver significant shareholder value", added: "While sources of capital for, and the risks inherent in, early-stage businesses are challenges facing the group and its spin-out companies, the board remains confident that intellectual property and its commercialisation remain important factors in the economic development of the UK and other mature Western Economies. "This favourable long-term macro environment, coupled with the group's core competencies in this field, gives the directors confidence that the group remains well placed to deliver medium to long-term value for shareholders." NR Ip Group

Shares in this article

Related News

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track
3 Jun 2026

WINNERS & LOSERS: Howden's acquisition; B&M signals recovery on track

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

IP Group cheers trial results for Enterprise drug candidate
12 May 2026

IP Group cheers trial results for Enterprise drug candidate

(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms.

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint
7 May 2026

IN BRIEF: IP Group names Michael Queen as next chair, succeeding Flint

IP Group PLC - London-based investor in "breakthrough" science and technology firms - Appoints Michael Queen as chair designate, and as a non-executi...

Corporate News Ip Group + 1 more share